Prevalence of hepatitis C and related factors among beta-thalassemia major patients in Southern Iran in 2005-2006

Journal of Medical Sciences

Volumn 7, Issue 6, 2007, Pages 997-1002

  Ansari, Hossein ^a   Kamani, H ^a   Arbabi Sarjo, A ^a  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Beta thalassemia major; Hepatitis C; Prevalence

Indexed keywords

DEFEROXAMINE; HEPATITIS C ANTIBODY; IRON CHELATING AGENT;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD ANALYSIS; BLOOD GROUP; BLOOD GROUP O; BLOOD SAMPLING; BLOOD TRANSFUSION; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DEMOGRAPHY; DISEASE PREDISPOSITION; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFANT; INFORMATION PROCESSING; IRAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUESTIONNAIRE; SCREENING TEST; SEX DIFFERENCE;

EID: 37349123892     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2007.997.1002     Document Type: Article

References (14)

1. Abram, S. and E. Benenson, 1995. Control of communicable diseases manual. 6th Edn,. An Official report of the American Public Health Association.
2. Bastie, A., M. Pawlotsky and F. Roudot, 1995. Hepatitic C virus infection. Epidemiology abstract: Path-Biology. Paris, pp: 674-680.
3. El-ghohara, A., A. Hassan, Z. Noowman and O. Lavanchy, 1995. High prevalence of HCV among urban and rural population groups in Egypt: Acta Tropica, 15: 155-161.
4. Ghotbi, N. and T. Tsukatani, 2005. Evaluation of the national health policy of thalassaemia screening in the Islamic Republic of Iran. East. Mediterr. Health J., 11: 308-318.
5. Hajiani, E., R. Masjedizadeh, J. Hashemi, M. Azmi and T. Rajabi, 2006. Hepatis C virus transmission and its risk factors within families of patients infected with hepatitis C virus in southern Iran: Khuzestan. World J. Gastroenterol., 12: 7025-7028.
6. Jules, L., K. Dienstage and I. Bacher, 1999. Harrisons Principles Internal Medicine. 14th Edn., Mc Graw-Hill Company, pp: 1686-1900.
7. Karamifar, H., M. Shahriari and N. Sadjadian, 2003. Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran. East Mediterr Health J., 9: 55-60.
8. Karimi, M., H. Yarmohammadi, S. Farjadian, S. Zeinali, Z. Moghaddam, M.D. Cappellini and P.C. Giordano, 2002. Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G->A) is the prevalent thalassemia intermedia allele. Hemoglobin, 26: 147-154.
9. Melody, J., J. Ellis and R. Alan, 2004. Complications of beta-thalassemia major in North American. Blood, 104: 34-39.
10. Mirmomen, S., S.M. Alavian, B. Hajarizadeh, J. Kafaee, B. Yektaparast, M.J. Zahedi, V. Zand, A.A. Azami, M.M. Hosseini, A.R. Faridi, K. Davari and B. Hajibeigi, 2006. Epidemiology of hepatitis B, hepatitis C and human immunodeficiency virus infecions in patients with beta-thalassemia in Iran: A multicenter study. Arch. Iran Med., 9: 319-323.
11. Peter, G. and C. Hepatitic, 1997. Red Book Committee on Infectious Disease. American Academy of Pediatrics, pp: 260-264.
12. Sheila, S.H. and D. James, 1999. HCV: Disorder of Liver and Biliary System. 9th Edn., Oxford. Black Well Scientific Publication, pp: 283-284.
13. Tamaddoni, A., I. Mohammadzadeh and O. Ziaei, 2007. Seroprevalence of HCV antibody among patients with beta-thalassemia major in Amirkola Thalassemia Center, Iran. Iran J. Allergy Asthma Immunol., 6: 41. 2006.
14. WHO, 1998. The 50th Anniversary of WHO. Weekly Epidemiological Record WHO, 20: 145-152.